Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses

Frontiers in Immunology(2020)10.3389/fimmu.2020.606338Source: DataRank Database

Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.87)OA: goldTopics (81)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Gisela Gabernet ORCID,Gildas Lepennetier ORCID,Simon Heumos ORCID,Miriam Kaminski,Zsuzsanna Hracskó

Live enrichment

PubMed:33391273 OpenAlex:https://openalex.org/W3113737607

Medizinischen Fakultät, Eberhard Karls Universität Tübingen

Grant: fortüne/PATE no 2536-0-0

Bundesministerium für Bildung und Forschung

Grant: 01ZX1301F, 01GI1601D , 01ZZ1804[A-I]

Deutsche Forschungsgemeinschaft

Grant: EXC 2180-390900677, SFB/TR 209, EXC 2145 SyNergy – ID 390857198

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 4R01EY022936-04

Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis Optica

FWCI

2.87

Citation Percentile

0.9%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.606338/pdf

GOLDhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.606338/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.606338/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.606338/full

journalhttps://doi.org/10.3389/fimmu.2020.606338

Fields of Study

T-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies ResearchPeripheral Neuropathies and DisordersBiologyMedicine0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Immunogenicity, VaccineAdolescentAdultAgedAged, 80 and overAntibodies, ViralB-LymphocytesCommunicable DiseasesEncephalitis Viruses, Tick-BorneFemaleHumansInflammationInfluenza VaccinesLymphocyte ActivationMaleMiddle AgedPhenotypeVaccinationViral VaccinesCase-Control StudiesTumor Necrosis Factor Receptor Superfamily, Member 7Antigens, CD19Antigens, CD20Cell ProliferationYoung AdultImmunity, HumoralTranscriptome

Keywords

ImmunologyMemory B cellCD19B cellBiologyImmune systemPopulationAntibodyAntigenImmunoglobulin DNaive B cellVirologyT cellMedicineAntigen-presenting cellAdultMaledouble negative B cellsAdolescentAntigens, CD19Antibodies, ViralLymphocyte ActivationCommunicable Diseasesautoimmune disordersTBE vaccinationEncephalitis Viruses, Tick-BorneImmunogenicity, VaccineAutoimmune Disorders ; B Cells ; Double Negative B Cells ; Influenza Vaccination ; Neuromyelitis Optica Spectrum Disorder ; Tbe Vaccination ; VaccinationDDC Classification::6 Technik, Medizin, angewandte Wissenschaften :: 61 Medizin und Gesundheit :: 610 Medizin und GesundheitHumansAgedCell ProliferationAged, 80 and overInflammationB cellsB-Lymphocytesneuromyelitis optica spectrum disorderRC581-607vaccinationAntigens, CD20influenza vaccinationImmunity, HumoralInfluenza VaccinesCase-Control StudiesFemaleImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being